Krishna Institute of Medical Sciences has made further investment by acquiring an additional equity stake of 3.00% in Arunodaya Hospitals, subsidiary company of the Company. Consequently, the Company now holds 70.66% of the total paid-up equity share capital of Arunodaya Hospitals. Powered by Capital Market - Live

Gross revenue stood at Rs 782 crore during the quarter, registering a growth of 19.4% on YoY basis. Profit before tax grew 11.47% YoY to Rs 99.1 crore in the quarter ended 30 September 2024. Consolidated EBITDA increased by 23.8% YoY to Rs 223 crore and EBITDA margin rose to 28.7% in Q2 FY25 as against 27.6% in Q2 FY24. Krishna Institute's average revenue per occupied bed (ARPOB) rose by 22.9% YoY to Rs 38,263. Average revenue per patient (ARPP) grew by 9.7% YoY to Rs 1,40,316. The company conducted 4.73 lakhs OPD consults in Q2 FY25, which increased by 12.2% on YoY basis. Dr. B Bhaskar Rao, CMD, KIMS Hospitals, said: 'The second quarter has been an extremely busy and productive one on multiple fronts for us. Our unit in Nashik went live this quarter and we are happy to say that we have started our first hospital in Kerala at Kannur. All our units are working to their optimal capacity to meet the rush of patients across all geographies. We have been focusing on ensuring that our mission to provide affordable and accessible quality healthcare reaches everyone effectively. We are confident and on track to achieve our targets for FY 25.' Headquartered in Hyderabad, Krishna Institute of Medical Sciences (KIMS Hospitals) is one of the largest corporate healthcare groups in Telangana and Andhra Pradesh, providing multi-disciplinary integrated healthcare services, with a focus on tertiary and quaternary healthcare at affordable cost.Powered by Capital Market - Live

Net profit of Krishna Institute of Medical Sciences rose 16.71% to Rs 107.40 crore in the quarter ended September 2024 as against Rs 92.02 crore during the previous quarter ended September 2023. Sales rose 19.13% to Rs 777.30 crore in the quarter ended September 2024 as against Rs 652.48 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales777.30652.48 19 OPM %28.0627.17 - PBDT203.20171.22 19 PBT162.20138.62 17 NP107.4092.02 17 Powered by Capital Market - Live

The company intends to develop new medical facilities and acquire 3000 beds in the state over the next five years in Kerala. KIMS Hospitals, currently has presence in the 5 states of Telangana, Andhra Pradesh, Maharashtra, Kerala and Karnataka with over 16 hospitals and 5000 plus beds. In a regulatory filing made post market hours today, the company stated that it has already begun operations in Kerala by taking over Sreechand Hospital in Kannur and entering into an O&M contract with Westfort Hospital at Thrissur, where further development work is underway. Over the next two years, the group plans to establish new hospitals in Kerala developing large health cities in Kochi and Kozhikode, each with 800-bed capacities. The group's expansion blueprint includes setting up a fully equipped oncology and transplant centre in Kannur, along with a 350-bed hospital in Thrissur dedicated to advanced transplant services. In future plans, KIMS intends to acquire hospitals in Calicut and Trivandrum. In the distant future, it plans to explore possibility of opening one hospital in all districts of Kerala. All our units will mostly be asset light model. Dr Bhaskar Rao, chairman and manging director, KIMS Hospitals said: 'Our sole aim is to bring accessible and affordable clinical healthcare services with world-class amenities to the people of Kerala and ensure that no patient in need is deprived of treatment due to financial constraints. Headquartered in Hyderabad, Krishna Institute of Medical Sciences Limited (KIMS Hospitals) is one of the largest corporate healthcare groups in Telangana and Andhra Pradesh, providing multi-disciplinary integrated healthcare services, with a focus on tertiary and quaternary healthcare at affordable cost. The hospital chain operator had reported 7.18% increase in consolidated net profit to Rs 86.6 crore in Q1 FY25 from Rs 80.8 crore posted in Q1 FY24. Revenue from operations rose by 13.6% year on year (YoY) to Rs 688.4 crore during the quarter ended June 2024. The scrip had gained 0.49% to end at Rs 559.30 on the BSE today. Powered by Capital Market - Live

Krishna Institute of Medical Sciences (KIMS) Hospitals has announced the expansion into Kerala, to develop new medical facilities and acquire 3000 beds in the state over the next five years. KIMS Hospitals, currently has presence in the 5 states of Telangana, Andhra Pradesh, Maharashtra, Kerala and Karnataka with over 16 hospitals and 5000 plus beds. KIMS has already begun operations in Kerala by taking over Sreechand Hospital in Kannur and entering into an O&M contract with Westfort Hospital at Thrissur, where further development work is underway. Over the next two years, the group plans to establish new hospitals in Kerala developing large health cities in Kochi and Kozhikode, each with 800-bed capacities. The group's expansion blueprint includes setting up a fully equipped oncology and transplant centre in Kannur, along with a 350-bed hospital in Thrissur dedicated to advanced transplant services. In future plans, KIMS intends to acquire hospitals in Calicut and Trivandrum. In the distant future, it plans to explore possibility of opening one hospital in all districts of Kerala. All our units will mostly be asset light model. Powered by Capital Market - Live

Krishna Institute of Medical Sci. will hold a meeting of the Board of Directors of the Company on 9 November 2024Powered by Capital Market - Live

Krishna Institute of Medical Sciences (KIMS) signed a Memorandum of Understanding (MoU) to procure medical technology and services of Upto Rs 700 crore with Wipro GE Healthcare, a leading global medical technology, diagnostics, and digital solutions innovator. As part of this MoU, Wipro GE Healthcare will be an end-to-end medical technology partner for KIMS providing new products, replacements, and service to the existing and new branches of the hospital system over the next 3 years. The MoU covers full suite of medical technology products designed, developed and manufactured by Wipro GE Healthcare including PET CTs, SPEC CTs, Cath labs, MRIs, CT Scanners, ultrasounds, and critical care equipment, among others. Powered by Capital Market - Live

Krishna Institute of Medical Sciences has fixed 13 September 2024 as record date for determining the eligibility of shareholders of the Company for sub-division/ split of 1 equity share having a face value of Rs.10 each, fully paid-up, be sub-divided into 5 equity shares having a face value of Rs.2 each, fully paid-up.Powered by Capital Market - Live

Zomato Ltd, Praj Industries Ltd, Angel One Ltd, UTI Asset Management Company Ltd are among the other stocks to see a surge in volumes on BSE today, 20 August 2024.Krishna Institute of Medical Sciences Ltd witnessed volume of 7.81 lakh shares by 10:46 IST on BSE, a 147.38 times surge over two-week average daily volume of 5300 shares. The stock dropped 1.29% to Rs.2,346.85. Volumes stood at 11102 shares in the last session.Zomato Ltd notched up volume of 2028.12 lakh shares by 10:46 IST on BSE, a 57.93 fold spurt over two-week average daily volume of 35.01 lakh shares. The stock slipped 1.14% to Rs.259.30. Volumes stood at 57.54 lakh shares in the last session.Praj Industries Ltd clocked volume of 3.64 lakh shares by 10:46 IST on BSE, a 5.28 times surge over two-week average daily volume of 69004 shares. The stock gained 3.47% to Rs.779.20. Volumes stood at 77679 shares in the last session.Angel One Ltd registered volume of 2.74 lakh shares by 10:46 IST on BSE, a 4.05 fold spurt over two-week average daily volume of 67712 shares. The stock rose 8.43% to Rs.2,541.10. Volumes stood at 1.79 lakh shares in the last session.UTI Asset Management Company Ltd recorded volume of 30455 shares by 10:46 IST on BSE, a 3.77 times surge over two-week average daily volume of 8088 shares. The stock gained 4.80% to Rs.1,109.50. Volumes stood at 11057 shares in the last session.Powered by Capital Market - Live

Revenue from operations rose by 13.6% year on year (YoY) to Rs 688.4 crore during the quarter ended June 2024. Profit before tax in first quarter of FY25 stood at Rs 127.1 crore, up by 7.17% from Rs 118.6 crore posted in corresponding quarter a year ago. Consolidated EBITDA grew by 14.9% YoY to Rs 184 crore and consolidated EBITDA margin rose by 30 basis points YoY to 26.6% in June 2024 quarter. Krishna Institute's average revenue per occupied bed (ARPOB) rose by 6.1% YoY to Rs 38,458. Average revenue per patient (ARPP) grew by 21.3% YoY to Rs 1,39,398. The company conducted 4.2 lakhs OPD consults in Q1 FY25, which increased by 10.2% on YoY basis. Dr. B Bhaskar Rao, CMD, KIMS Hospitals, said: 'FY25 has begun on a robust note. Most of our units have performed as per targets, especially the newer ones of Nagpur and Sunshine. Clinical additions to key departments over the last few quarters have helped us serve our patients better and add to our topline too. Nashik unit will be operational this quarter and we are excited by the clinical talent that has come on board. I am optimistic that we are on track to achieve our targets for FY25.' Headquartered in Hyderabad, Krishna Institute of Medical Sciences Limited (KIMS Hospitals) is one of the largest corporate healthcare groups in Telangana and Andhra Pradesh, providing multi-disciplinary integrated healthcare services, with a focus on tertiary and quaternary healthcare at affordable cost. Powered by Capital Market - Live